New possibilities of infliximab administration in chronic inflammatory rheumatic diseases

New possibilities of infliximab administration in chronic inflammatory rheumatic diseases

Bibliographic Details
Main Authors:	A. I. Dubikov, E E Medved, E E Medved'
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2005-04-01
Series:	Научно-практическая ревматология
Online Access:	https://rsp.mediar-press.net/rsp/article/view/1670

Similar Items

New possibilities of movalis administration in rheumatic diseases
by: E. S. Tsvetkova, et al.
Published: (2003-08-01)

Intra-Articular Injections of Infliximab in the Treatment of Inflammatory Rheumatic Diseases: Case Reports and Review of Literature
by: A. Migliore, et al.
Published: (2010-01-01)

Response of Fibroblastic Rheumatism to Infliximab
by: Ricardo Romiti, et al.
Published: (2009-01-01)

New directions of pharmacotherapy of immune - inflammatory rheumatic diseases
by: E L Nasonov
Published: (2019-08-01)

Role of apoptosis in pathogenesis of rheumatoid arthritis and osteoarthritis
by: A I Dubikov, et al.
Published: (2005-02-01)

Chronic pain and central sensitization in immuno-inflammatory rheumatic diseases: pathogenesis, clinical manifestations, the possibility of using targeted disease modifying antirheumatic drugs
by: A. E. Karateev, et al.
Published: (2019-05-01)

Interleukin 6 inhibition: new possibilities of pharmacotherapy for immunoinflammatory rheumatic diseases
by: E L Nasonov, et al.
Published: (2013-11-01)

The chronic rheumatic diseases
by: Fletcher, E. T. D.
Published: (1944)

Cardiovascular safety of non-steroidal anti-inflammatory drugs in chronic inflammatory rheumatic diseases
by: B V Zavodovsky, et al.
Published: (2018-08-01)

POSSIBILITIES OF USING LEFLUNOMIDE IN RHEUMATIC DISEASES
by: E V Igolkina, et al.
Published: (2011-03-01)

POSSIBILITIES OF USING LEFLUNOMIDE IN RHEUMATIC DISEASES
by: E V Igolkina, et al.
Published: (2011-03-01)

USE OF INFLIXIMAB IN THE CASE OF INFLAMMATORY BOWEL DISEASE IN CHILDREN
by: N.E. Shchigoleva, et al.
Published: (2010-02-01)

USE OF INFLIXIMAB IN THE CASE OF INFLAMMATORY BOWEL DISEASE IN CHILDREN
by: N.E. Shchigoleva, et al.
Published: (2010-02-01)

Infliximab in inflammatory bowel disease
by: Konstantinos Papamichael, et al.
Published: (2019-03-01)

Obesity as a risk and severity factor in rheumatic diseases (Autoimmune Chronic inflammatory diseases-ACIDs)
by: Elisa eGremese, et al.
Published: (2014-11-01)

Postchikungunya Chronic Inflammatory Rheumatism
by: Keith A. Sacco, et al.
Published: (2016-01-01)

Reduction of Calciprotein Particles in Adults Receiving Infliximab for Chronic Inflammatory Disease
by: Mark K Tiong, et al.
Published: (2021-06-01)

Janus kinase inhibitors in immuno-inflammatory rheumatic diseases: new opportunities and prospects
by: E. L. Nasonov, et al.
Published: (2019-03-01)

Arthroscopic synovectomy in chronic inflammatory rheumatism: clinical and functional aspects
by: A. Murgo, et al.
Published: (2003-03-01)

Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases
by: Aikaterini Arida, et al.
Published: (2018-06-01)

Lactulose administration for correction of stool disturbances in patients with rheumatic diseases
by: A E Karateev
Published: (2008-12-01)

Role of nitric oxide in musculoskeletal system diseases (part II)
by: A. I. Dubikov, et al.
Published: (2004-08-01)

NEW POSSIBILITIES OF PHARMACOTHERAPY FOR IMMUNOINFLAMMATORY RHEUMATIC DISEASES: A FOCUS ON INHIBITORS OF INTERLEUKIN-17
by: E. L. Nasonov
Published: (2017-03-01)

Evaluation of the safety and satisfaction of rheumatic patients with accelerated infliximab infusion
by: Jozélio Freire de Carvalho, et al.
Published: (2018-08-01)

Management of inflammatory bowel disease in poor responders to infliximab
by: Guerra I, et al.
Published: (2014-09-01)

Inflammatory bowel disease of the lung: The role of infliximab?
by: Adam J. Hayek, et al.
Published: (2015-01-01)

The role of chemokines and their receptors in chronic rheumatic diseases
by: Amft, E. Nicole
Published: (2001)

BARICITINIB: NEW PHARMACOTHERAPY OPTIONS FOR RHEUMATOID ARTHRITIS AND OTHER IMMUNE-MEDIATED INFLAMMATORY RHEUMATIC DISEASES
by: E. L. Nasonov, et al.
Published: (2020-06-01)

Functional magnetic resonance imaging for chronic pain in patients with rheumatic diseases
by: E. S. Filatova, et al.
Published: (2019-12-01)

EFFICACY AND SAFETY OF TOFACITINIB FOR IMMUNEMEDIATED INFLAMMATORY RHEUMATIC DISEASES (PART II)
by: E. L. Nasonov, et al.
Published: (2020-04-01)

Rheumatic diseases and multimorbidity
by: E L Nasonov, et al.
Published: (2015-05-01)

PROSPECTS FOR ANTI-B-CELL THERAPY IN IMMUNO-INFLAMMATORY RHEUMATIC DISEASES
by: e L. Nasonov, et al.
Published: (2019-12-01)

OSTEOPOROSIS AND ASSOCIATED FRACTURES IN OLDER PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES
by: E N Gladkov, et al.
Published: (2015-12-01)

INHIBITION OF INTERLEUKIN 6 IN IMMUNE INFLAMMATORY RHEUMATIC DISEASES: ACHIEVEMENTS, PROSPECTS, AND HOPES
by: E. L. Nasonov, et al.
Published: (2018-01-01)

Metabolic syndrome in inflammatory rheumatic diseases
by: G. La Montagna, et al.
Published: (2011-09-01)

Vaccinations in autoimmune inflammatory rheumatic diseases
by: Leszek Szenborn
Published: (2016-12-01)

Efficacy and safety of tofacitinib for immune-mediated inflammatory rheumatic diseases (Part I)
by: E. L. Nasonov, et al.
Published: (2020-02-01)

Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases
by: Edgard Torres dos Reis Neto, et al.
Published: (2020-06-01)

The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases
by: Giovanni Cioffi, et al.
Published: (2021-03-01)

Is safety infliximab during pregnancy in patients with inflammatory bowel disease?
by: Federico Argüelles-Arias, et al.